393 related articles for article (PubMed ID: 24664809)
41. Comprehensive Discovery and Quantitation of Protein Heterogeneity via LC-MS/MS Peptide Mapping for Clone Selection of a Therapeutic Protein.
Traylor MJ; Tchoudakova AV; Lundquist AM; Gill JE; Boldog FL; Tangarone BS
Anal Chem; 2016 Sep; 88(18):9309-17. PubMed ID: 27569415
[TBL] [Abstract][Full Text] [Related]
42. Liquid chromatography-tandem mass spectrometry-based fragmentation analysis of glycopeptides.
Nilsson J
Glycoconj J; 2016 Jun; 33(3):261-72. PubMed ID: 26780731
[TBL] [Abstract][Full Text] [Related]
43. Enrichment and identification of bacterial glycopeptides by mass spectrometry.
Scott NE; Cordwell SJ
Methods Mol Biol; 2015; 1295():355-68. PubMed ID: 25820733
[TBL] [Abstract][Full Text] [Related]
44. Analytical comparability assessment on glycosylation of ziv-aflibercept and the biosimilar candidate.
Shen Z; Wang Y; Xu H; Zhang Q; Sha C; Sun B; Li Q
Int J Biol Macromol; 2021 Jun; 180():494-509. PubMed ID: 33684428
[TBL] [Abstract][Full Text] [Related]
45. Site-Specific N- and O-Glycopeptide Analysis Using an Integrated C18-PGC-LC-ESI-QTOF-MS/MS Approach.
Stavenhagen K; Hinneburg H; Kolarich D; Wuhrer M
Methods Mol Biol; 2017; 1503():109-119. PubMed ID: 27743362
[TBL] [Abstract][Full Text] [Related]
46. Development of Immobilized Enzyme Reactors for the characterization of the glycosylation heterogeneity of a protein.
Perchepied S; Eskenazi N; Giangrande C; Camperi J; Fournier T; Vinh J; Delaunay N; Pichon V
Talanta; 2020 Jan; 206():120171. PubMed ID: 31514875
[TBL] [Abstract][Full Text] [Related]
47. Development and application of a robust N-glycan profiling method for heightened characterization of monoclonal antibodies and related glycoproteins.
Shang TQ; Saati A; Toler KN; Mo J; Li H; Matlosz T; Lin X; Schenk J; Ng CK; Duffy T; Porter TJ; Rouse JC
J Pharm Sci; 2014 Jul; 103(7):1967-1978. PubMed ID: 24840237
[TBL] [Abstract][Full Text] [Related]
48. Strategy integrating stepped fragmentation and glycan diagnostic ion-based spectrum refinement for the identification of core fucosylated glycoproteome using mass spectrometry.
Cao Q; Zhao X; Zhao Q; Lv X; Ma C; Li X; Zhao Y; Peng B; Ying W; Qian X
Anal Chem; 2014 Jul; 86(14):6804-11. PubMed ID: 24914453
[TBL] [Abstract][Full Text] [Related]
49. Reliable determination of site-specific in vivo protein N-glycosylation based on collision-induced MS/MS and chromatographic retention time.
Wang B; Tsybovsky Y; Palczewski K; Chance MR
J Am Soc Mass Spectrom; 2014 May; 25(5):729-41. PubMed ID: 24549892
[TBL] [Abstract][Full Text] [Related]
50. Simple capillary electrophoresis-mass spectrometry method for complex glycan analysis using a flow-through microvial interface.
Jayo RG; Thaysen-Andersen M; Lindenburg PW; Haselberg R; Hankemeier T; Ramautar R; Chen DD
Anal Chem; 2014 Jul; 86(13):6479-86. PubMed ID: 24873509
[TBL] [Abstract][Full Text] [Related]
51. Determination of site-specific glycan heterogeneity on glycoproteins.
Kolarich D; Jensen PH; Altmann F; Packer NH
Nat Protoc; 2012 Jun; 7(7):1285-98. PubMed ID: 22678432
[TBL] [Abstract][Full Text] [Related]
52. Monitoring multiple quality attributes of a complex Fc-fusion protein during cell culture production processes by mD-LC-MS peptide mapping.
Camperi J; Dahotre S; Guillarme D; Stella C
Talanta; 2022 Aug; 246():123519. PubMed ID: 35525056
[TBL] [Abstract][Full Text] [Related]
53. Reductive chemical release of N-glycans as 1-amino-alditols and subsequent 9-fluorenylmethyloxycarbonyl labeling for MS and LC/MS analysis.
Wang C; Qiang S; Jin W; Song X; Zhang Y; Huang L; Wang Z
J Proteomics; 2018 Sep; 187():47-58. PubMed ID: 29885470
[TBL] [Abstract][Full Text] [Related]
54. Resolving Isomeric Glycopeptide Glycoforms with Hydrophilic Interaction Chromatography (HILIC).
Huang Y; Nie Y; Boyes B; Orlando R
J Biomol Tech; 2016 Sep; 27(3):98-104. PubMed ID: 27582638
[TBL] [Abstract][Full Text] [Related]
55. Peptide-N-glycosidase F or A treatment and procainamide-labeling for identification and quantification of N-glycans in two types of mammalian glycoproteins using UPLC and LC-MS/MS.
Kim A; Kim J; Park CS; Jin M; Kang M; Moon C; Kim M; Kim J; Yang S; Jang L; Jang JY; Kim HH
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jan; 1214():123538. PubMed ID: 36493594
[TBL] [Abstract][Full Text] [Related]
56. Large-scale characterization of intact N-glycopeptides using an automated glycoproteomic method.
Cheng K; Chen R; Seebun D; Ye M; Figeys D; Zou H
J Proteomics; 2014 Oct; 110():145-54. PubMed ID: 25182382
[TBL] [Abstract][Full Text] [Related]
57. Orthogonal liquid chromatography-mass spectrometry methods for the comprehensive characterization of therapeutic glycoproteins, from released glycans to intact protein level.
Largy E; Cantais F; Van Vyncht G; Beck A; Delobel A
J Chromatogr A; 2017 May; 1498():128-146. PubMed ID: 28372839
[TBL] [Abstract][Full Text] [Related]
58. HILIC-UPLC-MS for high throughput and isomeric N-glycan separation and characterization in Congenital Disorders Glycosylation and human diseases.
Messina A; Palmigiano A; Esposito F; Fiumara A; Bordugo A; Barone R; Sturiale L; Jaeken J; Garozzo D
Glycoconj J; 2021 Apr; 38(2):201-211. PubMed ID: 32915358
[TBL] [Abstract][Full Text] [Related]
59. Assessing the hydrophobicity of glycopeptides using reversed-phase liquid chromatography and tandem mass spectrometry.
Wang J; Yu A; Cho BG; Mechref Y
J Chromatogr A; 2023 Sep; 1706():464237. PubMed ID: 37523904
[TBL] [Abstract][Full Text] [Related]
60. Characterization of isomeric glycan structures by LC-MS/MS.
Veillon L; Huang Y; Peng W; Dong X; Cho BG; Mechref Y
Electrophoresis; 2017 Sep; 38(17):2100-2114. PubMed ID: 28370073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
